Understanding How Elacestrant Revolutionizes Cancer Treatment
Elacestrant is revolutionizing cancer treatment, particularly for hormone receptor-positive, HER2-negative metastatic breast cancer. Approved for postmenopausal women and adult men with ESR1 mutations, this oral therapy offers hope for those who have progressed on prior endocrine treatments. Explore its clinical efficacy, safety profile, and future potential in combination therapies, promising new pathways in cancer care. […]
3 minute read